NMP medical research institute
Jaipur, Rajasthan, 302019, India
Completed
NCT Number: NCT01933555
Impact of Women's Empowerment Program for Abused Pregnant Women
Although domestic violence is recognized as major threat in pregnancy, there is no intervention has been developed or test to support women in India. To evaluate the effect of women's empowerment program administered to abused women in order to reduce domestic abuse, improving health status and safety behavior.
Completed
Looking for future studies?
Notify MeKey information
Conditions
Age range
18 year–35 year
Sex eligibility
Female
Study type
Interventional
Phase
Phase 2
Primary location
Who can participate
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- at least 18 years of age,
- victims of intimate partner violence, and
- willing to participate
Exclusion criteria
- women whose abuser was not their intimate partner or
- who were unable to consent
Treatment and study plan
Empowerment Program
BehavioralPrimary outcomes
-
Quality of life(Sf-36)
Time frame: Five Months
Secondary outcomes
-
Post natal depression
Time frame: 5 months
Other outcomes
-
Domestic Violence Inventory and safety seeking behavior
Time frame: 5 months
Sponsors and collaborators
Lead sponsor
Macmillan Research Group UK
Industry
Registry information
Official study title
Impact of Women's Empowerment Program for Abused Pregnant Women: A Randomized Controlled Trial
Important dates
- Study start
- 2013
- Primary completion
- 2013
- Study completion
- 2013
- First posted
- Sep 2, 2013
- Registry last updated
- Sep 2, 2013
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.